Literature DB >> 19898927

Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from Benin.

Julie Lajoie1, Johanne Poudrier, Marguerite Massinga Loembe, Fernand Guédou, François Leblond, Annie-Claude Labbé, Michel Alary, Michel Roger.   

Abstract

INTRODUCTION: Understanding the genital mucosal immunity and the factors involved in linking innate to adaptive immunity is crucial for the design of efficient preventive strategies against human immunodeficiency virus (HIV)-1.
METHODS: Levels of both genital mucosal and blood chemokines were compared between 58 HIV-1-uninfected and 50 HIV-1-infected female commercial sex workers (CSWs) as well as 53 HIV-1-uninfected non-CSW control women at low risk for exposure, recruited in Cotonou, Benin.
RESULTS: HIV-1-infected CSWs had significantly higher blood and genital levels of monocyte chemotactic protein (MCP-3/CCL7) and monokine induced by gamma interferon (MIG/CXCL9) compared with those in both the HIV-1-uninfected CSW and non-CSW groups. In the HIV-1-infected group, levels of MCP-3 and MIG were significantly higher in the genital mucosa than in the blood. However, the blood levels of macrophage inflammatory protein (MIP-1a/CCL3) and MIP-1b/CCL4 were higher in HIV-1-uninfected CSWs compared with those in the other groups.
CONCLUSION: Increased production of chemokines in the genital tract may favour the recruitment of HIV-1 target cells causing a mucosal environment that promotes viral replication and dissemination, whereas higher expression of beta-chemokines at the systemic level is associated with protection from HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898927     DOI: 10.1007/s10875-009-9343-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior.

Authors:  Taha Hirbod; Jakob Nilsson; Sonia Andersson; Caterina Uberti-Foppa; Davide Ferrari; Mara Manghi; Jan Andersson; Lucia Lopalco; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

Review 2.  Innate and adaptive immunity in female genital tract: cellular responses and interactions.

Authors:  Charles R Wira; John V Fahey; Charles L Sentman; Patricia A Pioli; Li Shen
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

3.  Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells.

Authors:  R N Fichorova; P J Desai; F C Gibson; C A Genco
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India.

Authors:  P Suresh; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2007-02       Impact factor: 2.205

5.  Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility.

Authors:  Rupert Kaul; Anuradha Rebbapragada; Taha Hirbod; Charles Wachihi; Terry B Ball; Francis A Plummer; Joshua Kimani; Walter Jaoko
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

6.  CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.

Authors:  Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

7.  Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells.

Authors:  David J Sharkey; Anne M Macpherson; Kelton P Tremellen; Sarah A Robertson
Journal:  Mol Hum Reprod       Date:  2007-05-05       Impact factor: 4.025

8.  Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Authors:  Claudia Devito; Jorma Hinkula; Rupert Kaul; Joshua Kimani; Peter Kiama; Lucia Lopalco; Claudia Barass; Stefania Piconi; Daria Trabattoni; Job J Bwayo; Francis Plummer; Mario Clerici; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

Review 9.  Critical issues in mucosal immunity for HIV-1 vaccine development.

Authors:  Barton F Haynes; Robin J Shattock
Journal:  J Allergy Clin Immunol       Date:  2008-05-12       Impact factor: 10.793

10.  Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Authors:  Nancy S Padian; Ariane van der Straten; Gita Ramjee; Tsungai Chipato; Guy de Bruyn; Kelly Blanchard; Stephen Shiboski; Elizabeth T Montgomery; Heidi Fancher; Helen Cheng; Michael Rosenblum; Mark van der Laan; Nicholas Jewell; James McIntyre
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

View more
  20 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

Review 2.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

3.  Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.

Authors:  Rada Ellegård; Elisa Crisci; Jonas Andersson; Esaki M Shankar; Sofia Nyström; Jorma Hinkula; Marie Larsson
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

Review 4.  Chemokine-mediated immune responses in the female genital tract mucosa.

Authors:  Maud Deruaz; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

5.  Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Authors:  Dara A Lehman; Keshet Ronen; Catherine A Blish; Jared M Baeten; Zahra Jalalian-Lechak; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; R Scott McClelland; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

6.  Preliminary studies on the use of pertussis toxin for the modulation of intravaginal SIV transmission in rhesus macaques.

Authors:  Kristina Ortiz; Rebecca S Sampathkumar; Aftab A Ansari; Siddappa N Byrareddy
Journal:  J Med Primatol       Date:  2017-09-21       Impact factor: 0.667

7.  Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial.

Authors:  Michael C Keefer; Bo Zheng; Alexander F Rosenberg; James J Kobie
Journal:  AIDS Res Hum Retroviruses       Date:  2016 Oct/Nov       Impact factor: 2.205

8.  Natural killer cell phenotype is altered in HIV-exposed seronegative women.

Authors:  Nancy Q Zhao; Elena Vendrame; Anne-Maud Ferreira; Christof Seiler; Thanmayi Ranganath; Michel Alary; Annie-Claude Labbé; Fernand Guédou; Johanne Poudrier; Susan Holmes; Michel Roger; Catherine A Blish
Journal:  PLoS One       Date:  2020-09-01       Impact factor: 3.240

9.  Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women.

Authors:  Jordan K Kyongo; Vicky Jespers; Odin Goovaerts; Johan Michiels; Joris Menten; Raina N Fichorova; Tania Crucitti; Guido Vanham; Kevin K Ariën
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

Review 10.  Natural Immunity to HIV: a delicate balance between strength and control.

Authors:  Johanne Poudrier; Valérie Thibodeau; Michel Roger
Journal:  Clin Dev Immunol       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.